A new trading day began on Monday, with Agios Pharmaceuticals Inc (NASDAQ: AGIO) stock price up 4.23% from the previous day of trading, before settling in for the closing price of $34.30. AGIO’s price has ranged from $23.42 to $62.58 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -20.91% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged -162.17%. With a float of $55.44 million, this company’s outstanding shares have now reached $57.89 million.
In an organization with 488 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 83.22%, operating margin of -1188.86%, and the pretax margin is 1917.72%.
Agios Pharmaceuticals Inc (AGIO) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Agios Pharmaceuticals Inc is 4.27%, while institutional ownership is 105.62%. The most recent insider transaction that took place on Apr 10 ’25, was worth 194,172. In this transaction Director of this company sold 7,497 shares at a rate of $25.90, taking the stock ownership to the 149,220 shares. Before that another transaction happened on Apr 08 ’25, when Company’s Director proposed sale 7,497 for $25.90, making the entire transaction worth $194,172.
Agios Pharmaceuticals Inc (AGIO) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around -162.17% per share during the next fiscal year.
Agios Pharmaceuticals Inc (NASDAQ: AGIO) Trading Performance Indicators
Here are Agios Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 17.93. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 55.91.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 11.29, a number that is poised to hit -1.81 in the next quarter and is forecasted to reach -6.64 in one year’s time.
Technical Analysis of Agios Pharmaceuticals Inc (AGIO)
Let’s dig in a bit further. During the last 5-days, its volume was 0.55 million. That was inferior than the volume of 0.67 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 70.31%. Additionally, its Average True Range was 1.39.
During the past 100 days, Agios Pharmaceuticals Inc’s (AGIO) raw stochastic average was set at 95.07%, which indicates a significant increase from 89.76% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 26.06% in the past 14 days, which was lower than the 44.29% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $29.83, while its 200-day Moving Average is $38.10. However, in the short run, Agios Pharmaceuticals Inc’s stock first resistance to watch stands at $36.84. Second resistance stands at $37.93. The third major resistance level sits at $39.46. If the price goes on to break the first support level at $34.21, it is likely to go to the next support level at $32.68. Assuming the price breaks the second support level, the third support level stands at $31.59.
Agios Pharmaceuticals Inc (NASDAQ: AGIO) Key Stats
With a market capitalization of 2.07 billion, the company has a total of 57,915K Shares Outstanding. Currently, annual sales are 36,500 K while annual income is 673,730 K. The company’s previous quarter sales were 8,730 K while its latest quarter income was -89,290 K.
